Publications by authors named "Ilaria Grassi"

Claim this Profile
E
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study.
Irene Marini, Emilio Francesco Giunta, Silvia Nicolini, Ilaria Grassi, Flavia Foca

Eur J Nucl Med Mol Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gain-of-function mutations in KATP channel subunits compromise colonic tight junction integrity and epithelial homeostasis in murine models of Cantú syndrome.
Fatima Maqoud, Domenica Mallardi, Antonella Orlando, Domenico Tricarico, Colin G Nichols, Ilaria Grassi

Front Med (Lausanne)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized Study.
Ilaria Grassi, Silvia Nicolini, Irene Marini, Federica Matteucci, Nicoletta Ranallo

Neuroendocrinology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Claudin 18.2: An attractive marker in pancreatic ductal adenocarcinoma.
Anna M Valentini, Graziana Arborea, Ilaria Grassi, Maria Teresa Savino, Nicoletta Labarile

Oncol Lett· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up.
Stefano Severi, Ilaria Grassi, Alberto Bongiovanni, Silvia Nicolini, Irene Marini

J Nucl Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating hsa-miR-5096 predicts F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors.
Martine Bocchini, Marcella Tazzari, Sara Ravaioli, Filippo Piccinini, Flavia Foca, Ilaria Grassi

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials.
Alberto Bongiovanni, Silvia Nicolini, Toni Ibrahim, Flavia Foca, Maddalena Sansovini, Ilaria Grassi

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.
Matt Lechner, Yoko Takahashi, Mario Turri-Zanoni, Jacklyn Liu, Nicholas Counsell, Ilaria Grassi

Eur J Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theragnostic in neuroendocrine tumors.
Irene Marini, Maddalena Sansovini, Alberto Bongiovanni, Silvia Nicolini, Ilaria Grassi

Q J Nucl Med Mol Imaging· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors.
Silvia Nicolini, Lisa Bodei, Alberto Bongiovanni, Maddalena Sansovini, Ilaria Grassi

Eur J Nucl Med Mol Imaging· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis.
Alberto Bongiovanni, Brigida Anna Maiorano, Irene Azzali, Chiara Liverani, Martine Bocchini, Ilaria Grassi

Pharmaceuticals (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study.
Giovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, Ilaria Grassi, Toni Ibrahim

Eur J Nucl Med Mol Imaging· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management-An Updated Review.
Martine Bocchini, Fabio Nicolini, Stefano Severi, Alberto Bongiovanni, Toni Ibrahim, Ilaria Grassi

Front Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods.
Maria Luisa Belli, Emilio Mezzenga, Valentina Di Iorio, Monica Celli, Paola Caroli, Ilaria Grassi

J Vis Exp· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and delayed evaluation of solid tumours with 64Cu-ATSM PET/CT: a pilot study on semiquantitative and computer-aided fractal geometry analysis.
Egesta Lopci, Fabio Grizzi, Carlo Russo, Luca Toschi, Ilaria Grassi

Nucl Med Commun· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to H.J.A. Adams et al and E. Laffon et al.
Michel Meignan, Anne Ségolène Cottereau, Annibale Versari, Loïc Chartier, Jehan Dupuis, Ilaria Grassi

J Clin Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of life.
Stefano Severi, Ilaria Grassi, Silvia Nicolini, Maddalena Sansovini, Alberto Bongiovanni

Onco Targets Ther· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.
Michel Meignan, Anne Ségolène Cottereau, Annibale Versari, Loïc Chartier, Jehan Dupuis, Ilaria Grassi

J Clin Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Evaluation of Disease Outcome in Solid Tumors Investigated With 64Cu-ATSM PET/CT.
Egesta Lopci, Ilaria Grassi, Domenico Rubello, Patrick M Colletti, Silvia Cambioli

Clin Nucl Med· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidentally detected increased FDG uptake in bowel and its correlation with hystopathological data: our experience in a case series study.
Ilaria Grassi, Paolo Castellucci, Cristina Nanni, Pietro Ghedini, Valentina Ambrosini

Curr Radiopharm· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.
Egesta Lopci, Ilaria Grassi, Arturo Chiti, Cristina Nanni, Gianfranco Cicoria

Am J Nucl Med Mol Imaging· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of 64Cu-ATSM in head and neck cancer: a preliminary prospective study.
Ilaria Grassi, Cristina Nanni, Gianfranco Cicoria, Claudio Blasi, Feisal Bunkheila

Clin Nucl Med· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical use of PET with (11)C-acetate.
Ilaria Grassi, Cristina Nanni, Vincenzo Allegri, Joshua James Morigi, Gian Carlo Montini

Am J Nucl Med Mol Imaging· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report.
Ilaria Grassi, Cristina Nanni, Valentina Vicennati, Paolo Castellucci, Vincenzo Allegri

Clin Nucl Med· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis